Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study

被引:1
|
作者
Hata, Shinnosuke [1 ]
Ushigome, Emi [1 ]
Yoshimura, Takashi [1 ]
Takegami, Maya [1 ]
Kitagawa, Nobuko [1 ]
Tanaka, Toru [2 ]
Hasegawa, Goji [3 ]
Ohnishi, Masayoshi [4 ]
Tsunoda, Sei [5 ]
Yokota, Isao [6 ]
Ushigome, Hidetaka [7 ]
Asano, Mai [1 ]
Hamaguchi, Masahide [1 ]
Yamazaki, Masahiro [1 ]
Fukui, Michiaki [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan
[2] Kyoto First Red Cross Hosp, Dept Endocrinol & Metab, Kyoto, Japan
[3] Kyoto Second Red Cross Hosp, Dept Endocrinol & Metab, Kyoto, Japan
[4] Osaka Gen Hosp West Japan Railway Co, Dept Endocrinol & Metab, Osaka, Japan
[5] Nishijin Hosp, Dept Cardiol, Kyoto, Japan
[6] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Biostat, Kyoto, Japan
[7] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Organ Transplantat & Gen Surg, Kyoto, Japan
关键词
cardiovascular events; home blood pressure measurement; maximum home blood pressure; multicenter study; type; 2; diabetes; USEFUL INDICATOR; HYPERTENSION; DISEASE; METAANALYSES; MANAGEMENT; MORTALITY; SURGE; RISK;
D O I
10.1097/HJH.0000000000003273
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: The maximum blood pressure was reported as a possible marker of organ damage. We previously showed that maximum home blood pressure was significantly associated with development of diabetic nephropathy. In the same cohort of patients with diabetes as in the previous study, this study aimed to evaluate the prognostic blood pressure values for the onset of first cardiovascular events. Methods: This retrospective cohort study included 1082 patients with type 2 diabetes (47.0% female, median age 65.0) without a history of macrovascular complications. Blood pressure measurements were performed in triplicates every morning and evening for 14 consecutive days from the start of the study. Cox hazards model was used to evaluate the risk of primary endpoint, which was defined as the onset of first major cardiovascular event. Results: The primary endpoint occurred in 119 patients (incidence rate, 15.7/1000 person-years) during an average of 7.0-year follow-up. The adjusted hazard ratios (95% confidence interval [CI]) of maximum morning systolic blood pressure (SBP) and maximum evening SBP for cardiovascular events were 1.12 (1.01-1.24) and 1.19 (1.07-1.31), respectively, adjusted by sex, duration of diabetes, body mass index, hemoglobin A1c, low density lipoprotein cholesterol, smoking status, and use of antihypertensive medications. The cutoff values of maximum blood pressure for the events were 150 mmHg in the morning (hazard ratio, 1.73; 95% CI, 1.07-2.81) and 157 mmHg in the evening (hazard ratio, 2.30; 95% CI, 1.46-3.61), using the Youden's index. Conclusion: Maximum home blood pressure is a predictor of subsequent cardiovascular events in patients with type 2 diabetes.
引用
收藏
页码:2430 / 2437
页数:8
相关论文
共 50 条
  • [1] Predictive power of home blood pressure measurement for cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
    Emi Ushigome
    Nobuko Kitagawa
    Noriyuki Kitagawa
    Toru Tanaka
    Goji Hasegawa
    Masayoshi Ohnishi
    Sei Tsunoda
    Hidetaka Ushigome
    Isao Yokota
    Naoto Nakamura
    Mai Asano
    Masahide Hamaguchi
    Masahiro Yamazaki
    Michiaki Fukui
    [J]. Hypertension Research, 2021, 44 : 348 - 354
  • [2] Predictive power of home blood pressure measurement for cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
    Ushigome, Emi
    Kitagawa, Nobuko
    Kitagawa, Noriyuki
    Tanaka, Toru
    Hasegawa, Goji
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Yokota, Isao
    Nakamura, Naoto
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. HYPERTENSION RESEARCH, 2021, 44 (03) : 348 - 354
  • [3] Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study
    Oyabu, Chikako
    Ushigome, Emi
    Matsumoto, Shinobu
    Tanaka, Toru
    Hasegawa, Goji
    Nakamura, Naoto
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Yokota, Isao
    Tanaka, Muhei
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (06): : 477 - 484
  • [4] Predictive power of isolated high home systolic blood pressure for cardiovascular outcomes in individuals with type 2 diabetes mellitus: KAMOGAWA-HBP study
    Hosomi, Yukako
    Ushigome, Emi
    Kitagawa, Nobuko
    Kitagawa, Noriyuki
    Tanaka, Toru
    Hasegawa, Goji
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Nakamura, Naoto
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2023, 20 (06):
  • [5] Home blood pressure is associated with cognitive impairment among elderly patients with type 2 diabetes: KAMOGAWA-HBP study
    Iwai, Keiko
    Ushigome, Emi
    Matsumoto, Shinobu
    Kitagawa, Nobuko
    Ushigome, Hidetaka
    Yokota, Isao
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (06): : 506 - 512
  • [6] Home-Measured Blood Pressure Is Associated with Handgrip Strength in Patients with Type 2 Diabetes: The KAMOGAWA-HBP Study
    Kimura, Tomonori
    Ushigome, Emi
    Hashimoto, Yoshitaka
    Nakanishi, Naoko
    Hamaguchi, Masahide
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [7] Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study
    Takegami, Maya
    Ushigome, Emi
    Hata, Shinnosuke
    Yoshimura, Takashi
    Kitagawa, Nobuko
    Hasegawa, Goji
    Tanaka, Toru
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Yokota, Isao
    Ushigome, Hidetaka
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (10) : 2330 - 2337
  • [8] Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study
    Kitagawa, Noriyuki
    Ushigome, Emi
    Matsumoto, Shinobu
    Oyabu, Chikako
    Ushigome, Hidetaka
    Yokota, Isao
    Asano, Mai
    Tanaka, Muhei
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (03): : 472 - 477
  • [9] Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study
    Okamura, Takuro
    Ushigome, Emi
    Kitagawa, Nobuko
    Oyabu, Chikako
    Tanaka, Toru
    Hasegawa, Goji
    Nakamura, Naoto
    Ohnishi, Masayoshi
    Tsunoda, Sei
    Ushigome, Hidetaka
    Yokota, Isao
    Hamaguchi, Masahide
    Asano, Mai
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (06) : 1543 - 1549
  • [10] Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA-HBP study
    Yoshimura, Takashi
    Ushigome, Emi
    Hata, Shinnosuke
    Takegami, Maya
    Hasegawa, Goji
    Tanaka, Toru
    Tsunoda, Sei
    Ohnishi, Masayoshi
    Yokota, Isao
    Ushigome, Hidetaka
    Kitagawa, Nobuko
    Asano, Mai
    Hamaguchi, Masahide
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2022, 24 (12): : 1561 - 1567